Navigation Links
Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013
Date:5/6/2013

13 American Society of Clinical Oncology (ASCO) Annual Meeting:Title:Preliminary results from a phase Ib/II, open-label, dose-escalation study of the oral BRAF inhibitor LGX818 in combination with the oral MEK1/2 inhibitor MEK162 in BRAF V600-dependent advanced solid tumors (Abstract #9029 / Poster board #17)Date:Monday, June 3, 8 am – 12-noon CDTIn addition, the data will be discussed during the poster discussion session on Monday, June 3 from 11:30 am – 12:30 pm CDT.Selumetinib – AstraZeneca to initiate two registration trials in 2013 and present data at ASCOAstraZeneca announced at their Analyst Day in March that they expect to initiate two pivotal trials with selumetinib in 2013.  The first will be with selumetinib in combination with docetaxel in KRAS-mutant non-small cell lung cancer based on the strength of the Phase 2 data AstraZeneca presented at ASCO 2012.  The second registration trial will be a pivotal trial with selumetinib in thyroid cancer.  Also during the event, AstraZeneca projected selumetinib peak annual sales to exceed $1 billion and suggested selumetinib may have potential application in high unmet need indications such as uveal melanoma, neurofibromatosis and gastrointestinal cancers.  In addition, AstraZeneca showed the advantages of selumetinib over GlaxoSmithKline's MEK inhibitor, trametinib, when combining with standard chemotherapy. 

The following oral presentations on selumetinib will be made by AstraZeneca at the ASCO annual meeting:Title:Phase II study of selumetinib versus temozolomide in gnaq/Gna11 mutant uveal melanoma (Abstract # CRA9003)Presenter:Richard D. Carvajal, MDDate:Saturday, June 1, 2:15 – 2:30 pm CDTTitle:Phase II double-blind, randomized study of selumetinib plus dacarbazine (DTIC) versus placebo plus DTIC as first-line treatment for advanced BRAF-mutant cutaneous or unknown primary melanoma (Abstract # 9004)  Presenter:Mark R. Middleton, PhD, FRCPDate:Saturd
'/>"/>

SOURCE Array BioPharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Global Array Instrument Market is Expected to Reach USD 3.2 Billion Globally in 2017: Transparency Market Research
2. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013
3. Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
4. Array BioPharma Announces Proposed Public Offering Of Common Stock
5. Array BioPharma Announces Pricing Of Public Offering Of Common Stock
6. Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference
7. InternetArray Collaborates with Health Sciences Group to Fund Medical Marijuana Social Media/Mobile Apps Development
8. Array BioPharma To Present At The Leerink Swann Global Healthcare Conference
9. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
10. Array BioPharma To Present At The Cowen Annual Health Care Conference
11. Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... LONDON , October 31, 2014 ... Nanosphere Inc. (NASDAQ: NSPH ), Isis Pharmaceuticals ... (NASDAQ: HALO ), ACADIA Pharmaceuticals Inc. (NASDAQ: ... SNTA). Free research on these five companies can be ... October 30, 2014, the NASDAQ Composite ended at 4,566.14, ...
(Date:10/31/2014)... BARCELONA , October 31, 2014 ... infringe two Australian patents of B. Braun Melsungen AG (B. ... Australia safety IV catheters manufactured by Poly Medicure ... Australia proceeding number VID 463 of ... In the detailed judgment, Multigate was found to have ...
(Date:10/31/2014)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... Isis Pharmaceuticals, Third Quarter 2014 Financial Results and Highlights ... a.m. ET / 8:30 a.m. PTWhere: , ... log onto our website listed above. If you are ... of the webcast will be available for a limited ...
Breaking Medicine Technology:Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 4Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 5B. Braun Wins Patent Disputes Against Poly Medicure Ltd's Australian Distributor Multigate Medical Devices Pty. Ltd. and Spanish Distributor Dextromédica S. L. 2Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 2Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 3
(Date:10/31/2014)... central to life. The last stage, when two daughter ... the dawn of cell biology in the Victorian era. ... to study this final step, when the dividing cell ... name given to this process by those early biologists, ... of a highly active and organized series of events. ...
(Date:10/31/2014)... The Memory Healer review published by DailyGossip.org ... whose father suffered from Alzheimer's disease. , In fact, ... his father's disease. His father pointed a gun and shot ... when the author of this method understood that he needed ... Memory Healer program is based on years of research. The ...
(Date:10/31/2014)... With all the preparations families carry ... they may overlook one critical area – the potential ... school performance and even behavior. Typical children’s vision screenings ... progressive vision problems, and to address this challenge, Dr. ... initiative: The Awesome Eyes Student Vision Program. , ...
(Date:10/31/2014)... increases the risk of certain types of breast cancer ... studies show. One study of more than 3,200 ... risk for estrogen receptor-negative and progesterone receptor-positive breast tumors ... long time for white women, but now we are ... John, a senior research scientist at the Cancer Prevention ...
(Date:10/31/2014)... Santa Barbara, CA (PRWEB) October 31, 2014 ... for holiday shoppers to find affordable but tasteful gifts for ... special 22nd Annual Early Bird Gift Giving Special , ... percent off when they purchase Wine Club Gift membership. ... to take advantage of this special. Besides offering discounts, Gold ...
Breaking Medicine News(10 mins):Health News:Cell division, minus the cells 2Health News:Cell division, minus the cells 3Health News:"Memory Healer" Review Reveals a New Natural Remedy Guide for Managing Memory Loss 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 3Health News:Study Confirms Obesity-Breast Cancer Link for Blacks, Hispanics 2Health News:Gold Medal Wine Club now offering Early Bird Gift Giving Special for Holidays 2
... Department of Emergency Medicine has received a two-year, $150,000 ... the implementation of electronic health records in a suburban ... work of Michael Ward, MD, an assistant professor at ... year focusing on simulation modeling in operations research, working ...
... , TUESDAY, June 7 (HealthDay News) -- Imaging ... a detrimental effect on the brain, according to a new ... of the drug caused a decrease in the number of ... bodily functions, including concentration, movement coordination, pleasure, pain tolerance, memory ...
... , TUESDAY, June 7 (HealthDay News) -- People ... do relatively few surgeries are at greater risk for serious ... were more common among patients at hospitals with low surgical ... according to the study, published online June 7 in ...
... sounds, smells and events: far too much for us to ... be snagged by something startling, such as a slamming door, ... to us right then, such as locating our child among ... know that people are hard-wired to seek out and pay ...
... (HealthDay News) -- Being in a serious relationship is not ... new research suggests. In fact, a study by researchers ... times more likely to have unprotected sex than casual partners. ... nearly 70 percent of all new HIV/AIDS diagnoses among adolescents ...
... U.S. Department of Agriculture (USDA)-funded studies of mammary gland ... interest may aid breast cancer research. In an early ... C. M. Simmen of the Arkansas Children,s Nutrition Center (ACNC) ... rat mammary gland health were improved in the offspring (pups) ...
Cached Medicine News:Health News:Using simulation to model the implementation of electronic health records 2Health News:Chronic Pot Smoking Affects Brain Chemistry, Scans Show 2Health News:Joint Replacement Risks Rise at Less Experienced Hospitals 2Health News:Your attention please: 'Rewarding' objects can't be ignored 2Health News:Your attention please: 'Rewarding' objects can't be ignored 3Health News:For Gay Men, Serious Relationships Still Harbor Risks for HIV 2Health News:Mammary gland development of blueberry-fed lab animals studied 2
Standard knife with box, C profile...
... necessary to cool a specimen below room temperature. ... most microtomes and will permit specimen cooling from ... The equipment consists of a cooling stage and ... suited for operation with a base sledge microtome, ...
... Stages fit easily onto most microtomes. These ... only the AC supply and a trickle of ... immediately and can be maintained indefinitely. Stage ... can be set for different kinds of tissue. ...
ELISA kit for the quantitative determination of autoantibodies to glutamic acid decarboxylase (GAD65) in serum...
Medicine Products: